Steven P Jones Selected Research

Steven P Jones Research Topics

Disease

17	Heart Failure 12/2021 - 04/2003
11	Infarction (Infarctions) 01/2020 - 04/2003
9	Hypertrophy 01/2022 - 06/2008
6	Myocardial Infarction 02/2015 - 09/2002
5	Hypoxia (Hypoxemia) 03/2011 - 06/2008
5	Myocardial Ischemia (Ischemic Heart Diseases) 06/2010 - 06/2002
4	Ischemia 01/2022 - 09/2002
3	Cardiomegaly (Heart Hypertrophy) 01/2018 - 12/2006
3	Fibrosis (Cirrhosis) 01/2017 - 11/2011
3	Mitochondrial Diseases (Mitochondrial Disease) 04/2015 - 10/2003
3	Reperfusion Injury 06/2010 - 09/2002
2	Ventricular Remodeling 10/2021 - 01/2019
2	Fatigue 09/2015 - 11/2010
2	Myocardial Reperfusion Injury 01/2004 - 01/2003
2	Necrosis 01/2003 - 09/2002
1	Inflammation (Inflammations) 12/2021
1	Metabolic Diseases (Metabolic Disease) 10/2021
1	Cleft Palate (Palate, Cleft) 01/2019
1	Cardiotoxicity 01/2019
1	Androgen-Insensitivity Syndrome (Testicular Feminization) 01/2018
1	Left Ventricular Dysfunction 01/2017
1	Insulin Resistance 07/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2014
1	Vascular System Injuries 05/2013
1	Coronary Occlusion 01/2012
1	Chronic Disease (Chronic Diseases) 07/2010
1	Anodontia (Hypodontia) 07/2010
1	Alzheimer Disease (Alzheimer's Disease) 12/2008
1	Pulmonary Edema 12/2006

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2006
6	EnzymesIBA 10/2021 - 01/2003
5	Glucose (Dextrose)FDA LinkGeneric 11/2017 - 12/2008
3	salicylhydroxamic acid (SHAM)IBA 01/2020 - 01/2012
3	FructoseIBA 11/2017 - 06/2008
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2017 - 06/2008
3	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2004 - 06/2002
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2004 - 09/2002
2	CollagenIBA 01/2022 - 01/2013
2	RNA (Ribonucleic Acid)IBA 12/2021 - 01/2013
2	Coenzyme A (CoA)IBA 10/2021 - 09/2002
2	Fatty Acids (Saturated Fatty Acids)IBA 10/2021 - 06/2008
2	AldehydesIBA 01/2018 - 01/2018
2	Phosphotransferases (Kinase)IBA 11/2017 - 06/2008
2	Transcription Factors (Transcription Factor)IBA 10/2015 - 05/2012
2	Pharmaceutical PreparationsIBA 02/2015 - 06/2010
2	hexosaminidase CIBA 03/2011 - 01/2009
2	O-GlcNAc transferaseIBA 03/2011 - 08/2008
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 03/2011 - 06/2010
2	Simvastatin (Zocor)FDA LinkGeneric 12/2006 - 10/2003
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2006 - 09/2002
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2004 - 04/2003
2	Oxidants (Oxidizing Agents)IBA 10/2003 - 01/2003
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2022
1	Benzene (Benzole)IBA 12/2021
1	Cell Adhesion MoleculesIBA 12/2021
1	KetonesIBA 10/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2021
1	RetinoidsIBA 01/2019
1	Acrolein (Aqualin)IBA 01/2018
1	Aldehyde DehydrogenaseIBA 01/2018
1	CytokinesIBA 11/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2016
1	Activating Transcription Factor 3IBA 10/2015
1	CyanoacrylatesIBA 09/2015
1	TroponinIBA 02/2015
1	Biomarkers (Surrogate Marker)IBA 02/2015
1	Branched-Chain Amino AcidsIBA 07/2014
1	Amino Acids FDA Link 07/2014
1	LipidsIBA 07/2014
1	NucleotidesIBA 07/2014
1	AcetylglucosamineIBA 04/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2013
1	lardIBA 01/2013
1	LuciferasesIBA 05/2012
1	CalcineurinIBA 05/2012
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 05/2012
1	Epoprostenol ReceptorsIBA 01/2012
1	ProstaglandinsIBA 01/2012
1	DNA (Deoxyribonucleic Acid)IBA 11/2011
1	DNA Glycosylases (DNA Glycosylase)IBA 11/2011
1	8-hydroxyguanineIBA 11/2011
1	Mitochondrial DNA (mtDNA)IBA 11/2011
1	Pyruvic Acid (Pyruvate)IBA 05/2011
1	Atrial Natriuretic Factor (ANF)IBA 04/2011
1	fluorexon (calcein)IBA 03/2011
1	N-acetylglucosaminono-1,5-lactone O-(phenylcarbamoyl)oxime (PUGNAC)IBA 03/2011
1	Transbond XTIBA 11/2010
1	TransbondIBA 11/2010
1	3-mercapto-2-methylpropionic acid (MMPA)IBA 07/2010
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2010
1	Mitochondrial Permeability Transition PoreIBA 06/2010
1	Apoptosis Inducing FactorIBA 06/2010
1	3,5-seco-4-norcholestan-5-one oxime-3-olIBA 06/2010
1	CalciumIBA 06/2010
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 06/2010
1	Hexosaminidases (Hexosaminidase)IBA 01/2009
1	Insulin (Novolin)FDA Link 12/2008

Therapy/Procedure

4	Therapeutics 01/2019 - 09/2002
2	Ligation 01/2017 - 12/2006
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020